Microbiome startup Sequentia Biotech heralds “new era” in omics with €10 million round
The Barcelona-based startup Sequentia Biotech has raised €10 million ($11 million) in a Series A round to finance the development of its omics-based technology for use in biomedicine, agritech and food.